Serum anti-Helicobacter pylori antibodies and the risk of chronic atrophic gastritis and gastric cancer

被引：0
|
作者：
Tsai, CJ
Zhang, ZF
Yu, GP
Kurtz, RC
机构：
[1] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90024 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
GASTROENTEROLOGY | 2000年 / 118卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(00)85176-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
4088
引用
收藏
页码：A760 / A760
页数：1
相关论文
共 50 条
  • [1] Serum anti-Helicobacter pylori antibodies and gastritis
    Yamamoto, I
    Fukuda, Y
    Mizuta, T
    Fukada, M
    Nishigami, T
    Shimoyama, T
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1995, 21 : S164 - S168
  • [2] Risk of gastric cancer development according to the combination of anti-Helicobacter pylori antibody titer and degree of atrophic gastritis.
    Lim, Joo Hyun
    Cho, Soo Jeong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 297 - 297
  • [3] Relationship between the presence of serum anti-Helicobacter pylori antibody and the extent of atrophic gastritis.
    Kawata, H
    Saifuku, K
    Satoh, K
    Kimura, K
    GASTROENTEROLOGY, 1998, 114 (04) : A172 - A172
  • [4] Association of Helicobacter pylori related chronic atrophic gastritis and gastric cancer risk: a literature review
    Zhang, Zefeng
    Chen, Sitong
    Li, Shudan
    Zheng, Yadan
    Mai, Lifei
    Zhang, Xiaoguang
    FRONTIERS IN MEDICINE, 2025, 12
  • [5] Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer
    Ohata, H
    Kitauchi, S
    Yoshimura, N
    Mugitani, K
    Iwane, M
    Nakamura, H
    Yoshikawa, A
    Yanaoka, K
    Arii, K
    Tamai, H
    Shimizu, Y
    Takeshita, T
    Mohara, O
    Ichinose, M
    INTERNATIONAL JOURNAL OF CANCER, 2004, 109 (01) : 138 - 143
  • [6] Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males
    Song, M.
    Camargo, M. C.
    Weinstein, S. J.
    Murphy, G.
    Freedman, N. D.
    Koshiol, J.
    Stolzenberg-Solomon, R. Z.
    Abnet, C. C.
    Mannisto, S.
    Albanes, D.
    Rabkin, C. S.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (04) : 494 - 503
  • [7] Helicobacter pylori infection on the risk of stomach cancer and chronic atrophic gastritis
    Zhang, ZF
    Kurtz, RC
    Klimstra, DS
    Yu, GP
    Sun, M
    Harlap, S
    Marshall, JR
    CANCER DETECTION AND PREVENTION, 1999, 23 (05): : 357 - 367
  • [8] ABO Genotype and the Risk of Gastric Cancer, Atrophic Gastritis, and Helicobacter pylori Infection
    Nakao, Makoto
    Matsuo, Keitaro
    Ito, Hidemi
    Shitara, Kohei
    Hosono, Satoyo
    Watanabe, Miki
    Ito, Seiji
    Sawaki, Akira
    Iida, Shinsuke
    Sato, Shigeki
    Yatabe, Yasushi
    Yamao, Kenji
    Ueda, Ryuzo
    Tajima, Kazuo
    Hamajima, Nobuyuki
    Tanaka, Hideo
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2011, 20 (08) : 1665 - 1672
  • [9] Helicobacter pylori, atrophic fundal gastritis and risk for gastric adenocarcinoma
    Iseki, K
    Tatsuta, M
    Iishi, H
    Hiyama, T
    Tsukuma, H
    Yokota, Y
    Ikeda, F
    ONCOLOGY REPORTS, 1997, 4 (04) : 809 - 813
  • [10] Serum CagA antibodies in Helicobacter pylori positive gastric cancer and chronic gastritis in Korea.
    Kim, HY
    Kim, YB
    Park, CK
    Yoo, JY
    GASTROENTEROLOGY, 1997, 112 (04) : A592 - A592
12345